About this event

  • Date and time Thu 30 Oct 2025 from 8:00am to 31 Oct 2025 at 6:00pm
  • Location Royal Society of 51¶ÌÊÓÆµ
  • Organised by Partner Symposium, Cleveland Clinic London

Cardiovascular disease (CVD) is the leading cause of death worldwide, highlighting the need for better education to improve care and outcomes.

Stay at the forefront of CVD with our two-day seminar bringing together experts from the UK and the US for a state-of-the-art review of the most significant changes, critical updates and recommendations to incorporate into your practice. Attendees can expect updates on cutting-edge science and the implementation of evidence-based guidelines, with the opportunity to network with fellow attendees and renowned speakers. In partnership with Cleveland Clinic’s Heart, Vascular and Thoracic Institute.

Topic highlights include:

  • Prevention and management of CVDÌý
  • Essentials of CADÌý
  • Heart failure and cardiomyopathiesÌý
  • Heart rhythmÌý
  • Diagnosis and management decisions in valve disease Ìý

This conference aims to:

  • Optimise management of dyslipidaemia, hypertension, obesity, and diabetes to reduce cardiovascular risk.
  • Explore innovations in diagnostics for screening, diagnosing, and treating CVD.
  • Assess medical and procedural strategies for atrial fibrillation, including prevention, risk assessment, and stroke prevention.
  • Prioritise heart failure treatments using evidence on pharmacotherapy, monitoring, and therapeutic devices.
  • Address special considerations in heart failure, including cardio-oncology, cardiogenic shock, critical care, cardio-obstetrics, cardiometabolic factors, cardiac amyloidosis, and HOCM.
  • Deliver evidence-based care for ischaemic heart disease.
  • Integrate the latest evidence on mitral and aortic valve disease, as well as aortic conditions, into clinical decisions for structural heart disease.

Target Audience

This course is designed for General Practitioners, Consultant Cardiologists, Cardiac Surgeons, nurses, and medical professionals involved in managing patients with cardiovascular disease.

Accreditation

In support of improving patient care, Cleveland Clinic Center for Continuing Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

American Medical Association (AMA)

Cleveland Clinic Center for Continuing Education has approved this live activity for AMA PRA Category 1 Creditsâ„¢. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.

Certificate of Participation

A certificate of participation will be provided to other healthcare professionals for requesting credits in accordance with their professional boards and/or associations.

Faculty Disclosure

The Cleveland Clinic Foundation Center for Continuing Education has implemented a policy to comply with the current Accreditation Council for Continuing Medical Education Standards for Integrity and Independence requiring mitigation of all faculty conflicts of interest. Faculty declaring a relevant financial relationship will be identified in the activity syllabus.

Cleveland Clinic is nationally ranked and globally recognised as a world leader in cardiovascular care.

Sponsorship and exhibit

For exhibiting or sponsoring this event, please contact Milena Kachar by emailing kacharm@ccf.org

Follow us on:





Tickets

Standard pricing available until 29 October 2025.

Member

RSM Associate
Day 1 Day 2
£18.00 Day 1
£18.00 Day 2
RSM Fellow
Day 1 Day 2
£18.00 Day 1
£18.00 Day 2
RSM Retired Fellow
Day 1 Day 2
£7.50 Day 1
£7.50 Day 2
RSM Student
Day 1 Day 2
£7.50 Day 1
£7.50 Day 2
RSM Trainee
Day 1 Day 2
£7.50 Day 1
£7.50 Day 2

Non - Member

Consultant / GP / SAS Doctors
Day 1 Day 2
£30.00 Day 1
£30.00 Day 2
AHP / Nurse / Midwife
Day 1 Day 2
£12.50 Day 1
£12.50 Day 2
Student
Day 1 Day 2
£12.50 Day 1
£12.50 Day 2
Trainee
Day 1 Day 2
£12.50 Day 1
£12.50 Day 2

Agenda

Day 1: View the programme 30 October 2025

Registration and breakfast
Welcome and Introduction

Lars Svensson & Olaf Wendler

Session 1: Prevention of cardiovascular disease

Chairs: Leslie Cho & Bernard Prendergast

Case scenario: Clinical presentation and initial assessment
Lipoprotein(a): New frontiers in risk reduction

Leslie Cho

Beyond statins: Alternative lipid lowering therapies to manage residual risk

Michael Papadakis

The asymptomatic patient with a high coronary calcium score: What next?

Milind DesaiÌýÌýÌýÌýÌý

The double jeopardy of diabetes and obesity: SGLT2i, GLP1RA or both?

Barbara McGowan

Old and evolving strategies for treatment-resistant hypertension

Ian Webb

Case scenario: Management strategy and clinical outcome
Panel Discussion - Audience Q&A
Tea and coffee break

Session 2 – Cardiovascular disease in specific patient subsets

Chairs: Christine Jellis & Mike Bellamy

Case scenario: Clinical presentation and initial assessment
Hormone therapy and the heart: Debunking myths, embracing evidence

Luna Siddique

Geriatric cardiology: Management of cardiovascular disease in elderly co-morbid patients

Amanda Vest

Cardio-oncology: Screening and key management considerations

Alex Lyon

Cardio-rheumatology: An emerging epidemic coming soon to a clinic near you

Taryn Youngstein

Sports cardiology: Screening of professionals (and wanabees) and prevention of sudden death

Sanjay Sharma

Cardio-obstetrics: Common problems and their management

Leslie Cho

Case scenario: Management strategy and clinical outcome
Panel discussion and Q&A
Lunch

Session 3: The essentials of ischaemic heart disease

Chairs: Ed Soltesz & Jonathan Byrne

Case scenario: Clinical presentation and initial assessment
Advanced multimodality imaging in ischaemic heart disease

Christine Jellis

Revascularization for stable angina and silent ischaemia: Current thinking

Julian Strange

Acute coronary syndromes: Pills, PCI and pitfalls

Mrin Saha

Ischaemic heart failure: Advanced strategies, revascularisation and circulatory support

Ed Soltesz

Cardiac rehabilitation: Who, how and when?

Leslie Cho

Case scenario: Management strategy and clinical outcome
Panel discussion and Q&A
Tea and coffee break

Session 4: Cardiomyopathies and heart failure

Chairs: Amanda Vest & George Amin-Yousseff

Case scenario: Clinical presentation and initial assessment
Initiation and optimisation of guideline-directed medical therapy

Amanda Vest

Heart failure with preserved ejection fraction: Emerging aetiologies and treatments

Guy Lloyd

Hypertrophic cardiomyopathy: New diagnostic and therapeutic approaches

Milind Desai

Cardiogenic shock: Coronary care, intensive care and team-based networks

Ed Soltesz

Ablation of arrhythmias in heart failure: What can the electrophysiologist provide?

Oussama Wazni

Case scenario: Management strategy and clinical outcome
Panel discussion and Q&A
Close
Day 2: View the programme 31 October 2025

Breakfast
Welcome and announcements

Session 5: Heart rhythm management

Chairs: Oussama Wazni & Pier Lambiase

Case scenario: Clinical presentation and initial assessment
Screening for atrial fibrillation: Who, when and how?

Stuart Harris

Combined AF ablation and left atrial appendage closure: Future directions for stroke prevention

Oussama Wazni

Ablation of ventricular arrhythmias: New approaches and emerging technologies

Anthony Li

New frontiers in pacing: Lead-related complications and use of leadless devices

Aldo Rinaldi

Cardiac syncope: Diagnosis, investigation and treatment

Simon Sporton

Case scenario: Management strategy and clinical outcome
Panel discussion and Q&A
Tea and coffee break

Session 6: Valve disease I – Diagnosis and surveillance

Chairs: Marc Gillinov & Bernard Prendergast

Case scenario: Clinical presentation and initial assessment
The new ESC guidelines on valve disease – key messages for clinical practice

Bushra Rana

Echocardiographic assessment of valve disease: A career’s worth of tips and tricks

Brian Griffin

Earlier intervention for aortic stenosis: Emerging evidence and clinical practice

Milind Desai

Patient selection for mitral and tricuspid valve intervention: What does the referrer need to know?

Jonathan Byrne

Multiple valve disease: Which high risk combinations need referral – and when?

Sanjeev Battacharya

Case scenario: Management strategy and clinical outcome
Panel discussion and Q&A
Lunch

Session 7: Valve disease II – Transcatheter intervention and surgery

Chairs: Simon Redwood & Samir Kapadia

Case scenario: Clinical presentation and initial assessment
Transcatheter aortic valve implantation: Innovation and evolution

Tom Cahill

Lifetime management of aortic stenosis: The remaining role of surgery

Olaf Wendler

Modern mitral valve surgery: Staying ahead of the game

Marc Gillinov

Transcatheter mitral and tricuspid valve intervention: Where are we and where are we going?

Samir Kapadia

Beyond valve disease: Further offerings from the structural interventionist

Sam Dawkins

Case scenario: Management strategy and clinical outcome
Panel discussion and Q&A
Tea and coffee break

Session 8: Complex aortic and peripheral vascular disease

Chairs: Olaf Wendler & Lars Svensson

Case scenario: Clinical presentation and initial assessment
Vascular screening and surveillance: Diagnosis, medical therapy and referral for surgery

Joseph Shalloub

Thoracic aortopathy with or without valve disease: Optimal assessment with multimodality imaging

Milind Desai

Advances in aortic valve and root surgery: TAVI is not always the answer!

Lars Svensson

Vascular surgery below the diaphragm: Expanding indications and collaborative working

Mark Tyrell

Beyond surgery: Interventional and hybrid approaches

Ed Soltesz

Case scenario: Management strategy and clinical outcome
Panel discussion and Q&A
Closing remarks

Lars Svensson & Olaf WendlerÌýÌý

Close of meeting

Location

Royal Society of 51¶ÌÊÓÆµ, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom

Disclaimers:Ìý

Registration for this event will close on 29 October 2025 at 8:00pm (BST). Late registrations will not be accepted.Ìý

The agenda is subject to change at any timeÌýÌý

All views expressed at this event are of the speakers themselves and not of the Royal Society of 51¶ÌÊÓÆµ, nor the speaker's organisations.Ìý